Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2+ Breast Cancer Metastasis to the Brain. (Q46014242)

18 December 2017

http://europepmc.org/abstract/MED/29061641

title

Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2+ Breast Cancer Metastasis to the Brain. (English)

1 reference

18 December 2017

http://europepmc.org/abstract/MED/29061641

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Christine E Brown

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Saul J Priceman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Dileshni Tilakawardane

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Brook Jeang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Brenda Aguilar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Anthony K Park

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Wen-Chung Chang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Julie R Ostberg

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Josh Neman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Rahul Jandial

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Jana Portnow

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Stephen J Forman

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

language of work or name

English

0 references

publication date

23 October 2017

1 reference

18 December 2017

http://europepmc.org/abstract/MED/29061641

published in

Clinical Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

95-105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial

5 June 2020

cites work

1 reference

12 December 2020

Leptomeningeal metastasis in breast cancer - a systematic review

1 reference

12 December 2020

Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain

1 reference

12 December 2020

Chimeric antigen receptor T cells for sustained remissions in leukemia

1 reference

12 December 2020

Phenotypic and functional attributes of lentivirus-modified CD19-specific human CD8+ central memory T cells manufactured at clinical scale

1 reference

12 December 2020

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

1 reference

12 December 2020

Humanization of an anti-p185HER2 antibody for human cancer therapy

1 reference

12 December 2020

Efficacy of CAR T-cell therapy in large tumors relies upon stromal targeting by IFNγ.

1 reference

12 December 2020

Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression.

1 reference

12 December 2020

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect

1 reference

12 December 2020

Cancer Statistics, 2017.

1 reference

12 December 2020

Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy

1 reference

12 December 2020

Stem-like tumor-initiating cells isolated from IL13Rα2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T Cells

1 reference

12 December 2020

4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors

1 reference

12 December 2020

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

1 reference

12 December 2020

Human breast cancer metastases to the brain display GABAergic properties in the neural niche

1 reference

12 December 2020

Breast cancer brain metastases: the last frontier

1 reference

12 December 2020

Construction and evaluation of a novel humanized HER2-specific chimeric receptor

1 reference

12 December 2020

Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directions

1 reference

12 December 2020

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

1 reference

12 December 2020

Smart CARs engineered for cancer immunotherapy

1 reference

12 December 2020

Human antibody RNase fusion protein targeting CD30+ lymphomas.

1 reference

12 December 2020

Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor

1 reference

12 December 2020

Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacy

1 reference

12 December 2020

Protein L: a novel reagent for the detection of chimeric antigen receptor (CAR) expression by flow cytometry

1 reference

12 December 2020

Thermodynamic consequences of mutations in vernier zone residues of a humanized anti-human epidermal growth factor receptor murine antibody, 528

1 reference

12 December 2020

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer

1 reference

12 December 2020

Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice

1 reference

12 December 2020

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma.

1 reference

12 December 2020

Human epidermal growth factor receptor family-targeted therapies in the treatment of HER2-overexpressing breast cancer

1 reference

12 December 2020

Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

1 reference

12 December 2020

Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL.

1 reference

12 December 2020

10.1158/1078-0432.CCR-17-2041

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29061641%20AND%20SRC:MED&resulttype=core&format=json

release_oaigpyietbe4dcm4emg5zjenfy

5 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oaigpyietbe4dcm4emg5zjenfy

24 November 2022

mapped directly with Wikidata item

PMC publication ID

7685198

0 references

1 reference